In collaboration with MedTech Leading Voice and AKRA TEAM, a webinar will be held to discuss the European Commission’s December 2025 proposal to revise the IVDR.
The amendment introduces several major regulatory changes, including:
- redesigned conformity assessment pathways,
- expanded provisions for in‑house devices,
- new innovation routes,
- adjusted performance study requirements.
The session will highlight the main elements of the proposal, their practical impact, and what manufacturers should anticipate as the legislative process evolves.
Tom Patten, IVDR/IVD International Manager, will join the discussion and share GMED’s perspective.
share
Events
Find an answer to the challenges you are facing in one of our upcoming events: trainings, webinars, forums...